fulvestrant has been researched along with daidzein in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 12 (57.14) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, D; Boue, SM; Burow, ME; Collins-Burow, BM; Driver, J; Elliott, S; Jiang, Q; McLachlan, JA; Payton-Stewart, F; Rhodes, LV; Sridhar, J; Stevens, C; Wang, G; Wiese, TE; Zhang, Q; Zheng, S | 1 |
| Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
| Dopp, E; Grevesmühl, Y; Hahnel, C; Schiffmann, D; Vollmer, G | 1 |
| Hill, NS; Karamsetty, MR; Klinger, JR | 1 |
| Diel, P; Michna, H; Olff, S; Schmidt, S | 1 |
| Chaumaz, G; Cournot, G; Lieberherr, M; Pointillart, A; Rassi, CM | 1 |
| Anderson, JJ; Chen, X | 1 |
| Finking, G; Hanke, H; Lenz, C; Schochat, T | 1 |
| Cross, HS; Farhan, H; Wähälä, K | 1 |
| Eyster, KM; Martin, DS; Rodrigo, MC | 1 |
| Aihara, H; Hong, T; Ikehara, T; Ito, T; Kim, MY; Kraus, WL; Muramatsu, M; Nakagawa, T; Pan, W; Takebe, M; Yasui, K | 1 |
| Colin, C; De Wilde, A; Lieberherr, M; Pointillart, A | 1 |
| Boujaoude, M; Missen, MA; Woodman, OL | 1 |
| Leung, LK; Yuen, YM | 1 |
| Atkin, SL; Ghavideldarestani, M; Lindow, SW; Saurabh, R; Xu, SZ; Zhong, W | 1 |
| Kim, YH; Kumazoe, M; Tachibana, H; Tsukamoto, S; Yamada, K; Yamashita, S | 1 |
| Kawamura, Y; Michihara, S; Moriyama, T; Tanaka, T; Uzawa, Y | 1 |
| Kajta, M; Krzeptowski, W; Lason, W; Lenartowicz, M; Litwa, E; Rzemieniec, J; Wojtowicz, AK | 1 |
| Robb, EL; Stuart, JA | 1 |
| Li, L; Li, LZ; Li, ZY; Sun, J; Sun, WJ; Wang, C; Wang, Y; Yu, LR; Zhang, YL; Zhao, Y | 1 |
| Huang, SH; Jin, X; Sun, J; Sun, WJ; Wang, Y; Xie, WL; Yang, J; Yu, B | 1 |
1 review(s) available for fulvestrant and daidzein
| Article | Year |
|---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
20 other study(ies) available for fulvestrant and daidzein
| Article | Year |
|---|---|
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoflavones; Mice; Mice, Nude; Models, Molecular; Receptors, Progesterone; Response Elements; Structure-Activity Relationship; Transcription, Genetic; Xenograft Model Antitumor Assays | 2010 |
Modulation of the intracellular calcium level in mammalian cells caused by 17beta-estradiol, different phytoestrogens and the anti-estrogen ICI 182780.
Topics: Actins; Animals; Calcium; Chlorocebus aethiops; COS Cells; Coumestrol; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Fulvestrant; Genistein; Intracellular Fluid; Isoflavones; Phytoestrogens; Plant Preparations; Rats; Receptors, Estrogen; Tumor Cells, Cultured | 1999 |
Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
Topics: Animals; Carbachol; Cholinergic Agonists; Chronic Disease; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Isoflavones; Male; Nitric Oxide; Nitric Oxide Synthase; Phytoestrogens; Plant Preparations; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Topics: Blotting, Western; Breast; Coumestrol; Diet; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Humans; Isoflavones; Molecular Structure; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured | 2001 |
Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Topics: Acid Phosphatase; Animals; Apoptosis; Bone Marrow Cells; Calcitriol; Caspase 3; Caspases; Cell Differentiation; Cells, Cultured; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Fulvestrant; Isoenzymes; Isoflavones; Osteoclasts; Receptors, Estrogen; Swine; Tartrate-Resistant Acid Phosphatase | 2002 |
Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
Topics: Cell Division; Cell Survival; DNA; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Genistein; Glycine max; Humans; Interleukin-6; Isoflavones; Ovarian Neoplasms; Receptors, Estrogen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured | 2001 |
Reduction of post injury neointima formation due to 17beta-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro.
Topics: Animals; Aorta; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Fulvestrant; Genistein; Isoflavones; Phytoestrogens; Plant Preparations; Pulmonary Artery; Rabbits; Random Allocation; Tunica Intima | 2002 |
Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Cell Division; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Histone Deacetylases; Humans; Hydroxamic Acids; Isoflavones; Male; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steroid Hydroxylases; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Vitamin D; Vitamin D3 24-Hydroxylase | 2003 |
Vascular ECE-1 mRNA expression decreases in response to estrogens.
Topics: Animals; Aspartic Acid Endopeptidases; Drug Therapy, Combination; Endothelin-Converting Enzymes; Estradiol; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Genistein; Isoflavones; Mesenteric Arteries; Metalloendopeptidases; Oligonucleotide Array Sequence Analysis; Ovariectomy; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Isoflavones stimulate estrogen receptor-mediated core histone acetylation.
Topics: Acetylation; Acetyltransferases; Animals; Cell Line; Drosophila; Equol; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Histone Acetyltransferases; Histones; Isoflavones; Nuclear Proteins; Nuclear Receptor Coactivator 2; Receptors, Estrogen; Recombinant Proteins; Spodoptera; Tamoxifen; Trans-Activators; Transcription Factors; Transcription, Genetic | 2004 |
A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
Topics: Alkaline Phosphatase; Animals; Blotting, Western; Bone and Bones; Calcium; Carrier Proteins; Cell Division; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Cyclic AMP; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Fulvestrant; Glycoproteins; Isoflavones; Membrane Glycoproteins; Neoplasm Proteins; Osteoblasts; Osteocalcin; Osteoprotegerin; Procollagen; Progesterone; RANK Ligand; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Tumor Necrosis Factor; Swine; Time Factors; Transcription Factors | 2004 |
Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1.
Topics: Acetylcholine; Animals; Aorta; Body Weight; Calmodulin; Caveolin 1; Caveolins; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Estradiol; Fulvestrant; Gene Expression; Injections, Subcutaneous; Isoflavones; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Nitroprusside; Organ Size; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; Testis | 2004 |
Genistein and daidzein induced apoA-1 transactivation in hepG2 cells expressing oestrogen receptor-alpha.
Topics: Apolipoprotein A-I; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Genistein; Humans; Isoflavones; Phytoestrogens; Promoter Regions, Genetic; Protein Kinase Inhibitors; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured; Up-Regulation | 2008 |
Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
Topics: Apoptosis; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Estradiol; Estrogen Receptor beta; Fulvestrant; Genistein; Glucose; Glycine max; Humans; Hydrogen Peroxide; Isoflavones; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; rho-Associated Kinases; rhoA GTP-Binding Protein; Umbilical Veins | 2009 |
Isoflavones suppress the expression of the FcεRI high-affinity immunoglobulin E receptor independent of the estrogen receptor.
Topics: Animals; Anti-Allergic Agents; Basophils; Cell Line; Equol; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Glycine max; Humans; Immunoglobulin E; Isoflavones; Male; Mast Cells; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptors, Estrogen; Receptors, IgE | 2012 |
Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway.
Topics: Acid Phosphatase; Amino Acids; Animals; Breast Neoplasms; Cell Proliferation; Diet; Estradiol; Female; Fulvestrant; Humans; Isoflavones; MCF-7 Cells; Mice; Osteocalcin; Osteoporosis; Ovariectomy; Pueraria; Receptors, Estrogen | 2012 |
The key involvement of estrogen receptor β and G-protein-coupled receptor 30 in the neuroprotective action of daidzein.
Topics: Animals; Apoptosis; Benzodioxoles; Caspase 3; Cells, Cultured; Cerebellum; Estradiol; Estrogen Receptor beta; Fulvestrant; Glutamic Acid; Hippocampus; Isoflavones; Membrane Potential, Mitochondrial; Mice; Neocortex; Neurons; Neuroprotective Agents; Phosphorylation; Piperidines; Pyrazoles; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction | 2013 |
Multiple phytoestrogens inhibit cell growth and confer cytoprotection by inducing manganese superoxide dismutase expression.
Topics: Animals; Cell Cycle; Cell Line; Cell Proliferation; Coumestrol; Cytoprotection; Estradiol; Fulvestrant; Genistein; Isoflavones; Kaempferols; Mice; Myoblasts; Phytoestrogens; Receptors, Estrogen; Resveratrol; Stilbenes; Stress, Physiological; Superoxide Dismutase | 2014 |
Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells.
Topics: Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; Humans; Interleukin-6; Isoflavones; Nuclear Receptor Coactivator 1; Osteoblasts; Osteoprotegerin; Raloxifene Hydrochloride; RANK Ligand; RNA, Small Interfering | 2016 |
Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation.
Topics: Alkaline Phosphatase; Apoptosis; bcl-X Protein; Cell Differentiation; Cell Line; Cell Proliferation; Cisplatin; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Humans; Isoflavones; Osteoblasts; Osteogenesis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Signal Transduction | 2017 |